Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Nuvalent, Inc. - Class A Common Stock (NQ:NUVL)

97.41 -0.53 (-0.55%)

Streaming Delayed Price Updated: 1:57 PM EST, Jan 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	310,110
Open	96.99
Bid (Size)	97.29 (100)
Ask (Size)	97.52 (200)
Prev. Close	97.94
Today's Range	96.13 - 98.74
52wk Range	55.53 - 112.88
Shares Outstanding	3,129,384
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal

December 30, 2025

As 2025 draws to a close, the global financial landscape is bracing for what analysts are calling an "Innovation Supercycle" in the mergers and acquisitions (M&A) market. With interest rates finally...

Via MarketMinute

With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗

December 03, 2025

One investor is making a bold bet on Amylyx just as its 2026 catalyst calendar starts to take shape.

Via The Motley Fool

Performance

YTD	-3.4%	-3.4%
1 Month	-9.7%	-9.7%
3 Month	+16.2%	+16.2%
6 Month	+25.0%	+25.0%
1 Year	+24.7%	+24.7%

More News

Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗

December 03, 2025

Via The Motley Fool

Why Did Nuvalent Stock Surge 15% Today? ↗

November 17, 2025

Via Stocktwits

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Why Nuvalent (NUVL) Shares Are Down 6% Today ↗

September 17, 2024

Via Benzinga

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗

December 03, 2025

Via The Motley Fool

Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗

December 03, 2025

Via The Motley Fool

Biotech Stock Gets Booted in Latest Fund Update ↗

November 19, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 17, 2025

Via Benzinga

Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer ↗

November 17, 2025

Via Benzinga

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗

November 17, 2025

Via Benzinga

Nuvalent Unveils A New Promise For Hard-To-Treat Lung Cancer ↗

November 17, 2025

Via Investor's Business Daily

Wondering what's happening in today's after-hours session? ↗

November 14, 2025

Via Chartmill

This Waste Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

November 12, 2025

Via Benzinga

This Thermo Fisher Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

August 19, 2025

Via Benzinga

Nuvalent (NUVL) Q2 R&D Up 65% ↗

August 07, 2025

Via The Motley Fool

Nuvalent Inc-A (NASDAQ:NUVL) Reports Q2 2025 Earnings Miss with Focus on Oncology Pipeline Progress ↗

August 07, 2025

Via Chartmill

Nuvalent Touts 'Positive' Data From Zidesamtinib Trial For Pretreated Patients With Advanced Form Of Lung Cancer ↗

June 24, 2025

Via Benzinga

This American Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday ↗

December 30, 2024

Via Benzinga

This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

December 30, 2024

Via Benzinga

From Nuvalent to Nuvectis Pharma: New Report Highlights NXP900's Synergy in NSCLC and Anticipated NXP800 Data Update

October 28, 2024

Via News Direct

Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? ↗

September 22, 2024

Via Benzinga

Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity ↗

September 16, 2024

Via Benzinga

Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths ↗

September 16, 2024

Via Investor's Business Daily

Frequently Asked Questions

Is Nuvalent, Inc. - Class A Common Stock publicly traded?

Yes, Nuvalent, Inc. - Class A Common Stock is publicly traded.

What exchange does Nuvalent, Inc. - Class A Common Stock trade on?

Nuvalent, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Nuvalent, Inc. - Class A Common Stock?

The ticker symbol for Nuvalent, Inc. - Class A Common Stock is NUVL on the Nasdaq Stock Market

What is the current price of Nuvalent, Inc. - Class A Common Stock?

The current price of Nuvalent, Inc. - Class A Common Stock is 97.41

When was Nuvalent, Inc. - Class A Common Stock last traded?

The last trade of Nuvalent, Inc. - Class A Common Stock was at 01/06/26 01:57 PM ET

What is the market capitalization of Nuvalent, Inc. - Class A Common Stock?

The market capitalization of Nuvalent, Inc. - Class A Common Stock is 304.82M

How many shares of Nuvalent, Inc. - Class A Common Stock are outstanding?

Nuvalent, Inc. - Class A Common Stock has 305M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.